Replies to post #240 on Hepion Pharmaceuticals Inc (HEPA)

[OneDay4488]

CTRV Stock Price Forecast:
The 2 analysts offering 12-month price forecasts for ContraVir Pharmaceuticals Inc have a median target of 4.50, with a high estimate of 5.00 and a low estimate of 4.00. The median estimate represents a +91.49% increase from the last price of 2.35.

CTRV Analyst Recommendations:
The current consensus among 2 polled investment analysts is to buy stock in ContraVir Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a buy rating.

http://money.cnn.com/quote/forecast/forecast.html?symb=CTRV